Patients in the intermediate-risk (IR) group in clear-cell renal cell carcinoma (ccRCC), have a heterogeneous prognosis where elevated platelet count reflects the cancer-related inflammatory status.
from Medindia Health News https://ift.tt/3uQnknA
No comments:
Post a Comment